Assessment of health-related quality of life after hepatocellular carcinoma management (radiofrequency ablation or transarterial chemoembolization): a pilot Egyptian study

This study aimed to assess the effect of HCC and different locoregional HCC therapy [radiofrequency ablation (RFA) or transarterial chemoembolization (TACE)] on the HRQoL. Patients and methods Eighty HCC patients with CLD, 58 (72.5%) men and 22 (27.5%) women, mean age 51.8±6.2 years, were categorized into two groups. Group I included 40 HCC patients treated with RFA and group II included 40 HCC patients treated with TACE. The control Group included 40 CLD patients without HCC. HCC was managed according to the Barcelona Clinic Liver Cancer algorithm. The Short Form-36 questionnaires were filled in before and 1 month after the intervention. Results It was found that HRQoL in the control group was significantly better than in those who underwent TACE, but almost equal to those who underwent RFA. In group I, all parameters of HRQoL were statistically improved after RFA (P
Source: Egyptian Liver Journal - Category: Gastroenterology Tags: Original articles Source Type: research